Company: SXTPW
Filing Date: 2025-01-08
Form Type: 8-K
Source: 0001213900-25-002070
Chunk: 1

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-08
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are being filed herewith:

  Exhibit      Description                                            
      No.                                                             
     99.1      Press Release dated January 8, 2025                    
 ──────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the  

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

                             60 DEGREES PHARMACEUTICALS, INC.                                             
  Date: January 8, 2025      By:                                   /s/ Geoffrey Dow                       
                             Name:                                 Geoffrey Dow                           
                             Title:                                Chief Executive Officer and President